Scintigraphic prediction of therapeutic outcomes of splenectomy in patients with thrombocytopenia

Annals of Nuclear Medicine

Volumn 17, Issue 2, 2003, Pages 161-164

  Kinuya, Keiko ^a   Matano, Sadaya ^a   Nakashima, Hisayuki ^a   Taki, Suzuka ^b  

^a TONAMI GENERAL HOSPITAL   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Idiopathic thrombocytopenic purpura; Platelet scintigraphy; Splenectomy

Indexed keywords

8 QUINOLINOL INDIUM IN 111; ANTINEOPLASTIC AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ARTICLE; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HUMAN; HYPERSPLENISM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER METASTASIS; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECTUM CANCER; SCINTISCANNING; SPLENECTOMY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0038659962     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988457     Document Type: Article

References (18)

1. Ries CA. Platelet kinetics in autoimmune thrombocytopenia: Relation between splenic platelet sequestration and response to splenectomy. Ann Intern Med 1977; 86: 194-195.
2. Heyns A duP, Lotter MG, Badenhorst PN, Kock F, Pieters H, Herbst C, et al. Kinetics and site of destruction of In-111- oxine-labeled platelets in idiopathic thrombocytopenic purpura: A quantitative study. Am J Hematol 1982; 12: 167-177.
3. Fenaux P, Caulier MT, Hirschauer MC, Beuscart R, Goudemand J, Bauters F. Reevaluation of prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): A report on 181 cases. Eur J Haematol 1989;42:259-264.
4. Siegel RS, Rae JL, Barth S, Coleman RE, Reba RC, Kurlander R, et al. Platelet survival and turnover: Important factors in predicting response to splenectomy in immune thrombocytopenic purpura. Am J Hematol 1989; 30: 206-212.
5. Stratton JR, Ballem PJ, Gernsheimer T, Cerqueira M, Slichter SJ. Platelet destruction in autoimmune thrombocytopenic purpura: Kinetics and clearance of indium-111-labeled autologous platelets. J Nucl Med 1989; 30: 629-637.
6. Najean Y, Dufour V, Rain JD, Toubert ME. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. Br J Haematol 1991; 79: 271-276.
7. Lamy T, Moisan A, Dauriac C, Ghandour C, Morice P, Le Prise PY. Splenectomy in idiopathic thrombocytopenic purpura: Its correlation with the sequestration of autologous indium-111-labeled platelets. J Nucl Med 1993; 33: 182-186.
8. Uchida Y, Minoshima S, Miyazaki M, Kuyama J, Kitahara H, Ito H. Normalized spleen/liver ratios on In-111-labeled platelet scintigraphy to predict the outcome of partial splenic embolization in patients with idiopathic thrombocytopenic purpura. Nucl Med Commun 2000; 21: 441-447.
9. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995; 98: 436-442.
10. Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 74: 2309-2317.
11. Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric trial of the cooperative Latin American group on hemostasis and thrombosis. Blood 1984; 64: 1179-1183.
12. Julia A, Araguas C, Rossello J, Bueno J, Domenech P, Olona M, et al. Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 1990; 76: 250-255.
13. Fabris F, Zanatta N, Casonato A, Randi ML, Luzzatto G, Girolami A. Response to splenectomy in idiopathic thrombocytopenic purpura: Prognostic value of the clinical and laboratory evaluation. Acta Haemat 1989; 81: 28-33.
14. Castle VP, Shulkin BL, Coates G, Andrew M. The use of indium-111 oxine platelet scintigraphy and survival studies in pediatric patients with thrombocytopenia. J Nucl Med 1989; 30: 1819-1824.
15. Oriuchi N, Korkmaz M, Kim EE, Delpassand ES, Wong F, Wallace S, et al. Role of indium-111 labelled platelet scintigraphy in the management of thrombocytopenic patients with malignant neoplasms. Eur J Nucl Med 1998; 25: 247-252.
16. Hammersmith SM, Jacobson AF, Mankoff DA. Scintigraphy with indium-111-labeled homologous (donor) platelets in the platelet transfusion refractory bone marrow transplant patient. J Nucl Med 1997; 38: 1135-1138.
17. Becker W, Borst U, Krahe T, Borner W. Tc-99m-HMPAO labelled human platelets: in vitro and in vivo results. Eur J Nucl Med 1989; 15: 296-301.
18. 99mTc-HMPAO. Int J Rad Appl Instrum B 1991; 18: 461-468.